INM
INMED (INM) Falls Short of Nasdaq Equity Rule Ahead of Mentari Merger
InMed reported shareholders' equity of $1.08 million, below Nasdaq's $2.5 million minimum, and says its pending merger with Mentari should restore compliance.
INM
Market-moving news on InMed Pharmaceuticals (NASDAQ: INM): filings, earnings, deals and other events, from REDFILED.